HEATHER SHAFFER: Open Payments
NPI 1336496850 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 66 payments from 29 companies in 2025. Trend: 2023 $571 · 2024 $1,301 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $131 |
| Incyte Corporation | 6 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $125 |
| Janssen Biotech, Inc. | 6 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Genentech USA, Inc. | 4 | $87 |
| BeOne Medicines USA, Inc. | 3 | $80 |
| PFIZER INC. | 3 | $75 |
| Genmab U.S., Inc. | 3 | $68 |
| ABBVIE INC. | 2 | $56 |
Products named: Enhertu, BRUKINSA, KISQALI, XTANDI, Epkinly, RYBREVANT, JAKAFI, IMFINZI.
Industry payments across PA — which companies pay providers there.
